November 2006- Volume 2, Issue 11

November 2006

In this Issue

Editor's Focus

Metabolomics: Clearing the logjam for biomarkers

Metabolomics: Clearing the logjam for biomarkers

Although many analytical chemists and biochemists will claim they have been practicing the science of identifying small molecules in biological matrices long before 2000, most agree that as a robust discovery tool, the technology is new and rapidly evolving. Since then, there has been an explosion of papers describing the technology as well as a significant number of papers using the technology for the discovery of biomarkers.

Automation & Instrumentation

NimbleGen signs license deal with Affymetrix

NimbleGen signs license deal with Affymetrix

NimbleGen looking to diversify from its current service model.

Beckman Acquires Lumigen

Beckman Acquires Lumigen

Chemiluminescent chemistries to be used in Beckman Coulter’s Access immunoassay systems.

Is it easy being green?

Is it easy being green?

CEM, EPA collaborate on chemistry scale-up

Research & Development

NGI co-develops R&D office, incubator with U. Iowa

NGI co-develops R&D office, incubator with U. Iowa

Plans to build a new 80,000-sq.ft research center and business incubator.

Cardiovascular collaboration

Cardiovascular collaboration

Servier taps Plexxikon for non-peptidic rennin inhibitor project

Tag-teaming tuberculosis

Tag-teaming tuberculosis

Cumbre and TB Alliance announce partnership to develop new TB agents

Rx3 recieves two NIH grants

Rx3 recieves two NIH grants

Company wants to fight drug-resistant organisms.

Yale, NFCR launch cancer drug research center

Yale, NFCR launch cancer drug research center

Five-year, $750,000 grant to develop new beta-peptide inhibitors.

Global News

Microarrays have big future in store

Microarrays have big future in store

SNP market at about $400 million; in next 5 years to $1 billion.

Neurotech organization to advance brain, nervous system therapies

Neurotech organization to advance brain, nervous system therapies

Companies form a new trade association called the Neurotechnology Industry Organization (NIO).

Teva, Protalix collaborate on two biopharmaceuticals

Teva, Protalix collaborate on two biopharmaceuticals

Companies to develop two proteins using Protalix’s plant cell culture platform.

Informatics

Bundled biomarker deal

Bundled biomarker deal

InforSense, Thermo OEM agreement may accelerate protein biomarker discovery.

Scientists link gene behavior with disease and drugs

Scientists link gene behavior with disease and drugs

Connectivity Map opens doors to early prediction of effective or detrimental drug candidates.

BioIT Alliance targets biomarkers

BioIT Alliance targets biomarkers

BioIT Alliance begins the Biomarker Project and recruits Agilent.

3-D map of mouse brain gene expression

3-D map of mouse brain gene expression

The brain atlas details more than 21,000 genes at the cellular level.

Genomics & Proteomics

Enzyme market penetration

Enzyme market penetration

Millipore’s global reach will help get JPT’s enzyme line worldwide customers

Cogenics, Algynomics team up on pain panel

Cogenics, Algynomics team up on pain panel

Genetic markers to allow clients to examine the genetic basis or underpinnings of human pain.

Amgen acquires Avidia for $290 million

Amgen acquires Avidia for $290 million

Deal sees biotech giant pick up Avimer proteins platform.
Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

DDN Magazine May 2024

Latest Issue  

• Volume 20 • Issue 3 • May 2024

May 2024

May 2024 Issue